home / stock / otc:cc / otc:cc quote
Last: | $0.27 |
---|---|
Change Percent: | -5.26% |
Open: | $0.295 |
Close: | $0.27 |
High: | $0.3 |
Low: | $0.27 |
Volume: | 139,289 |
Last Trade Date Time: | 05/05/2022 04:56:22 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.27 | $0.295 | $0.27 | $0.3 | $0.27 | 139,289 | 05-05-2022 |
$0.285 | $0.295 | $0.285 | $0.295 | $0.28 | 10,185 | 05-04-2022 |
$0.245 | $0.245 | $0.245 | $0.245 | $0.245 | 2,685 | 05-03-2022 |
$0.25 | $0.235 | $0.25 | $0.29 | $0.235 | 59,764 | 05-02-2022 |
$0.285 | $0.285 | $0.285 | $0.285 | $0.285 | 12,260 | 04-29-2022 |
$0.285 | $0.3 | $0.285 | $0.3 | $0.285 | 13,490 | 04-28-2022 |
$0.3 | $0.3 | $0.3 | $0.3 | $0.3 | 9,304 | 04-27-2022 |
$0.275 | $0.29 | $0.275 | $0.29 | $0.275 | 18,361 | 04-26-2022 |
$0.295 | $0.29 | $0.295 | $0.295 | $0.29 | 37,560 | 04-25-2022 |
$0.29 | $0.28 | $0.29 | $0.29 | $0.28 | 12,109 | 04-22-2022 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.29 | 112,926 | 04-21-2022 |
$0.28 | $0.28 | $0.28 | $0.29 | $0.28 | 12,191 | 04-20-2022 |
$0.29 | $0.29 | $0.29 | $0.29 | $0.29 | 86,495 | 04-19-2022 |
$0.3 | $0.3 | $0.3 | $0.3 | $0.275 | 7,963 | 04-18-2022 |
$0.295 | $0.285 | $0.295 | $0.295 | $0.285 | 36,650 | 04-15-2022 |
$0.295 | $0.285 | $0.295 | $0.295 | $0.285 | 36,500 | 04-14-2022 |
$0.285 | $0.285 | $0.285 | $0.3 | $0.285 | 39,249 | 04-13-2022 |
$0.295 | $0.295 | $0.295 | $0.295 | $0.295 | 11,035 | 04-12-2022 |
$0.285 | $0.285 | $0.285 | $0.285 | $0.28 | 26,889 | 04-11-2022 |
$0.29 | $0.3 | $0.29 | $0.3 | $0.29 | 51,340 | 04-08-2022 |
News, Short Squeeze, Breakout and More Instantly...
Ocumetics Technology Corp. Company Name:
OTC:CC Stock Symbol:
TSXVC Market:
(TheNewswire) Calgary, Alberta – TheNewswire - February 29, 2024 - Ocumetics Technology Corp. (“Ocumetics”) (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO), is pleased to invite investors and other interested parties to attend an upcoming interview with Market Rad...
2024-01-08 16:00:00 ET Ocumetics Technology (TSXV:OTC,OTCQB:OTCFF, FWB:2QBO) has successfully completed a biocompatibility animal study for its proprietary Ocumetics Accommodating Lens, and according to President and CEO Dean Burns, the company is gearing up to commence its first ...
(TheNewswire) Calgary, Alberta – TheNewswire - December 21, 2023 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV:OTC) (OTC:OTCFF) (FRA:2QBO) is pleased to announce that the TSX Venture Exchange ha...